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Inflammatory Myofibroblastic Tumors
in the Uterus: Childhood-Case
Report and Review of the Literature
Péter Etlinger*, Levente Kuthi and Tamás Kovács
University of Szeged, Szeged, Hungary
Inflammatory myofibroblastic tumor (IMT) is a spindle cell neoplasm with low malignant
potential, which may appear in different parts of the body. Uterine localization is
rare, especially among children. Etiology is unclear, although some authors suggest
underlying trauma or distress. A 3.5-year-old girl was treated at our institute for recurring
vaginal bleeding without injury or known pathology. Physical examination and laboratory
analysis revealed no specific findings, contrast-enhanced MRI found a 25 × 28 ×
30 mm-sized inhomogeneous soft tissue mass in the uterus wall, which was excised
in toto. Histological examination identified a spindle cell pattern, and the FISH test
revealed ALK gene rearrangement, the lesion was defined as an IMT. Six cases were
published to date, and their diagnostic methods are not equivocal, CT, and PET CT were
preferred instead of MRI. Aggressive therapy seems to be exaggerated according to
low recurrence and metastasis occurrence, and crizotinib is proved as good therapeutic
agent in those cases. Biopsy and histology has important role in order to distinguish IMT
from malignancies completed with FISH examination because ALK positivity strengthens
the diagnosis. No lethal outcome was published among children, as our patient is also
symptom-free after 3 years.
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BACKGROUND
In the WHO definition, inflammatory myofibroblastic tumor (IMT) is a rare spindle cell neoplasm
with low malignant potential, and it is composed of proliferative myofibroblasts and mixed
inflammatory cell infiltrate. The appearance of IMT in childhood is extremely rare. Symptoms and
treatment are heterogeneous, mainly depend on the localization of the tumor (1–4). Genetically
speaking, approximately half of IMTs harbor clonal rearrangement of the anaplastic lymphoma
kinase (ALK) gene, which encodes receptor tyrosine kinase (1–5). Here, the authors present a
uterine-located IMT case and review the current literature data.
CASE REPORT
A 3.5-year-old girl was referred to the surgical outpatient clinic complaining of recurring vaginal
bleeding. There was no trauma or inflammatory symptoms in her clinical history. Regarding the
family history, no malignant, or genetic disease was noted. On physical examination flat and
non-tender abdomen was found without any palpable lumps, with negative rectal examination.
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FIGURE 1 | MRI image of the uterine lesion.
Abdominal ultrasound scan showed a mildly enlarged uterus,
while MRI examination identified a 25 × 28 × 30mm sized
inhomogeneous soft tissue mass in the uterus that compressed
the entire endometrium (Figure 1). The lesion enhanced contrast
material, and it did not spread through the serosa. AFP and LDH
values were in normal range, but NSE level was mildly elevated.
According to the multidisciplinary team’s decision, primary
open surgery was chosen. Fine needle biopsy was excluded
because of pelvic localization, small size, and the chance of
inadequate sample size for a certain histologic opinion. Tumor
spilling was also considered as risk factor during this procedure.
Surgery was performed through suprapubic incision; and the
well-circumscribed lesion seemed resectable, so instead of tumor
biopsy the entire mass was removed from the posterior wall
of the uterus. The myometrium was completely reconstructed.
Lymph node metastasis was not found. The postoperative
period was uneventful. After a 3-years follow-up period the
child was complaint-free, and the abdominal US scans showed
no recurrence. Histological examination revealed IMT with
irregular borders composed of spindle cells with low cytological
atypia. Also, an extensive inflammatory cell infiltrate with
eosinophyl granulocytes and lymphocytes was observed in
the tumor tissue. Immunohistochemistry was positive for h-
caldesmon, smooth muscle actin, CD34, factor XIII and ALK.
ALK FISH examination has found ALK translocation in 80% of
the tumor cells.
DISCUSSION
IMTs in children are seldom found, especially in uterine
localization (6). It usually appears in the lung or liver, but some
reports also mentioned other possible sites such as the stomach
(7), mesentery, omentum, retroperitoneum, head and neck
region, minor pelvis, urogenital tract, as well as extremities (2, 4).
Abbreviations: IMT, Inflammatory myofibroblastic tumor; ALK, Anaplastic
lymphoma kinase; MDT, Multidisciplinary team; AFP, Alpha-fetoprotein; LDH,
Lactate-dehydrogenase; NSE, Neuron-specific enolase; NPM, Nucleophosmin;
FISH, Fluorescence in situ hybridization; TPM4, Trophomyosine 4; CLTC,
Clathrin heavy chain.
Symptoms vary depending on the localization, e.g., palpable
mass, bleeding and vomiting, or bowel obstruction in abdominal
located IMTs (8). Etiology is unknown, however reports suggest
probability of previous injury, inflammation, or distress (8). In
the Pubmed© database only 6 reports concern pediatric uterine
IMT cases (6, 9–12). The spectrum of their clinical findings varied
from asymptomatic to severe physical signs such as abdominal
and pelvic pain (67%), weight loss (40%), fever (40%), and
menorrhagia (20%) (see Table 1). Tumor size ranged between 8
and 20 cm, while in our case maximum diameter was only 2.8 cm.
There is no single imaging method that is universally agreed
upon; contrast-enhanced CT (11) and PET-CT (10) were also
performed in different pediatric cases in order to detect activity
and metastases. Our chosen diagnostic modality was MRI for
its better soft tissue specificity and to avoid radiation exposure,
especially in the ovarian region. Interestingly, this tool has not
been used in pediatric uterine IMTs. Diagnostic laparoscopy was
performed prior to surgery in one case (11).
All six cases were treated surgically, four by hysterectomy
(9, 10, 12) and two by local tumor removal (6, 11). Depending
on the size and myometrial infiltration of the tumor, especially in
children, organ-sparing local excision was preferred; this was also
performed in our case.
Lymph node metastasis was present in one case without
progression during follow-up (10). One recurrence was observed
(6). She had the first local recurrence 1 month after the surgery,
although it could be the result of incomplete resection during
local excision (data not available), followed by two (ovarian and
unknown) recurrences treated successfully with crizotinib.
The overall recurrence rate for IMT is about 25%, while distant
metastases are very uncommon (2%) (2). Biological behavior
mostly depends on the size, mitotic activity, tumor cell necrosis
and resection line positivity (3). As some authors also reported,
recurrence can be the consequence of incomplete resection,
however in those cases no further relapse was detected (6, 8).
The histological appearance of each varied from case to case.
Immunohistochemistry revealed ALK-positivity in 4 cases as it
was also seen in our presented case. The expression of ALK
protein and the presence of ALK gene rearrangement are good
diagnostic markers; however, they are only present in about 50%
of the IMTs, but in 88–100% of uterine IMTs (4, 5, 13, 14). A
variable ALK-positivity can be seen in other tumor subtypes,
such as anaplastic large cell lymphoma, rhabdomyosarcoma,
and neuroblastoma (13), but in the case of female genital tract
tumors, it is considered as a specific marker of IMTs thus
supporting diagnosis. ALK translocation also offers a therapeutic
option, because ALK inhibitors like crizotinib and alectinib
can deactivate uncontrolled cell proliferation. ALK inhibitor
treatment is recommended in surgically incurable, metastatic and
recurrent cases (13, 14).
The “wait-and-see” approach was also described as a
safe treatment of IMTs in adults as well as in pediatric
cases (8, 15, 16). Data were also published about
spontaneous regression of a hepatic IMT (8). However, to
distinguish uterine IMTs from highly malignant tumors
like leiomyosarcoma, either a biopsy or an excision is
recommended. In contrast with pediatric cases, the outcome
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TABLE 1 | Literature data of pediatric IMTs.
References Age
(years)
Symptom Location Extent Treatment Tumor size
(cm)
Gross
appearance
Spindle
cell
pattern
Tumor border
Bennett et al. (6) 8 n/a n/a n/a Excision 20 n/a Compact n/a
Rabban et al. (9) 6 Abdominal pain Myometrium Filled endometrial
cavity
Hysterectomy 12 Flesh-like Fascicles Focally
irregular
Rabban et al. (9) 14 Weight loss, fever Myometrium Extent to
parametrium
Hysterectomy n/a Fibrous Hyalinized
nests
Focally
irregular
Fraggetta et al.
(10)
10 Menorrhagia, malaise,
abdominal discomfort,
pelvic pain
Endometrium Prolapse to
vagina
Hysterectomy 8 Polypoid
mass
Fascicular
pattern
n/a
Gupta et al. (11) 14 Abdominal pain,
nausea, weight loss,
fever
Myometrium n/a Excision 11 Trabecular Embedded
between
inflammatory
cells
n/a
Gilks et al. (12) 6 Abdominal pain,
distension
Myometrium Compressed
endometrial
cavity
Hysterectomy 12 Fleshy Fascicles Well-
circumscribed
is worse among adults. Two lethal outcomes and six
recurrences in 59 adult patients with uterine IMT were
found (6, 17).
In conclusion, the so far published youngest child with
uterine IMT was treated successfully by our team. To date,
no recurrence or metastasis has been observed. The authors
would also like to stress the role of the uterus-sparing
surgery to eliminate tumor or gain tissue specimen, and
emphasize the importance of the prior MRI imaging instead
of other reported methods in order to achieve recovery
without harming the normal development of the female
genital tract.
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